Logo image of GLTO

GALECTO INC (GLTO) Stock Overview

NASDAQ:GLTO - US36322Q2066 - Common Stock

3.36 USD
-0.04 (-1.18%)
Last: 8/26/2025, 2:43:36 PM

GLTO Key Statistics, Chart & Performance

Key Statistics
52 Week High14.82
52 Week Low2.01
Market Cap4.44M
Shares1.32M
Float1.28M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-17.62
PEN/A
Fwd PEN/A
Earnings (Next)10-30 2025-10-30
IPO10-29 2020-10-29
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


GLTO short term performance overview.The bars show the price performance of GLTO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20

GLTO long term performance overview.The bars show the price performance of GLTO in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of GLTO is 3.36 USD. In the past month the price decreased by -9.81%. In the past year, price decreased by -71.55%.

GALECTO INC / GLTO Daily stock chart

GLTO Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.61 366.84B
AMGN AMGEN INC 13.25 155.56B
GILD GILEAD SCIENCES INC 14.75 141.63B
VRTX VERTEX PHARMACEUTICALS INC 22.85 99.24B
REGN REGENERON PHARMACEUTICALS 12.75 61.69B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 58.56B
ARGX ARGENX SE - ADR 75.74 42.97B
ONC BEONE MEDICINES LTD-ADR 6.21 36.54B
INSM INSMED INC N/A 27.67B
BNTX BIONTECH SE-ADR N/A 24.97B
NTRA NATERA INC N/A 22.61B
BIIB BIOGEN INC 8.51 19.98B

About GLTO

Company Profile

GLTO logo image Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The company is headquartered in Boston, Massachusetts and currently employs 5 full-time employees. The company went IPO on 2020-10-29. The Company’s pipeline consists of small molecule drug candidates that target cancer and fibrosis signaling pathways, including a preclinical dual inhibitor of ENL-YEATS and FLT3 (GB3226) for multiple genetic subsets of AML; an orally active galectin-3 inhibitor (GB1211) in combination with a checkpoint inhibitor for various oncology indications and (an orally active galectin-3 inhibitor (GB1211) for the treatment of liver cirrhosis. The company is developing GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 for multiple molecularly defined subsets of acute myeloid leukemia (AML). The Company’s pipeline is GB1211, its oral small molecule galectin-3 inhibitor candidate, which is in development for the treatment of non-small cell lung cancer (NSCLC), melanoma, head and neck squamous cell carcinoma (HNSCC), and decompensated cirrhosis.

Company Info

GALECTO INC

75 State Street, Suite 100

Boston MASSACHUSETTS DK-2200 US

CEO: Hans T. Schambye

Employees: 5

GLTO Company Website

GLTO Investor Relations

Phone: 14570705210

GALECTO INC / GLTO FAQ

What is the stock price of GALECTO INC today?

The current stock price of GLTO is 3.36 USD. The price decreased by -1.18% in the last trading session.


What is the ticker symbol for GALECTO INC stock?

The exchange symbol of GALECTO INC is GLTO and it is listed on the Nasdaq exchange.


On which exchange is GLTO stock listed?

GLTO stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for GALECTO INC stock?

6 analysts have analysed GLTO and the average price target is 6.12 USD. This implies a price increase of 82.14% is expected in the next year compared to the current price of 3.36. Check the GALECTO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is GALECTO INC worth?

GALECTO INC (GLTO) has a market capitalization of 4.44M USD. This makes GLTO a Nano Cap stock.


How many employees does GALECTO INC have?

GALECTO INC (GLTO) currently has 5 employees.


What are the support and resistance levels for GALECTO INC (GLTO) stock?

GALECTO INC (GLTO) has a support level at 3.37 and a resistance level at 3.41. Check the full technical report for a detailed analysis of GLTO support and resistance levels.


Should I buy GALECTO INC (GLTO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does GALECTO INC (GLTO) stock pay dividends?

GLTO does not pay a dividend.


When does GALECTO INC (GLTO) report earnings?

GALECTO INC (GLTO) will report earnings on 2025-10-30.


What is the Price/Earnings (PE) ratio of GALECTO INC (GLTO)?

GALECTO INC (GLTO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-17.62).


What is the Short Interest ratio of GALECTO INC (GLTO) stock?

The outstanding short interest for GALECTO INC (GLTO) is 2.15% of its float. Check the ownership tab for more information on the GLTO short interest.


GLTO Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to GLTO. When comparing the yearly performance of all stocks, GLTO is a bad performer in the overall market: 93.25% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

GLTO Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to GLTO. The financial health of GLTO is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GLTO Financial Highlights

Over the last trailing twelve months GLTO reported a non-GAAP Earnings per Share(EPS) of -17.62. The EPS increased by 51.73% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -121.2%
ROE -151.5%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%47.19%
Sales Q2Q%N/A
EPS 1Y (TTM)51.73%
Revenue 1Y (TTM)N/A

GLTO Forecast & Estimates

6 analysts have analysed GLTO and the average price target is 6.12 USD. This implies a price increase of 82.14% is expected in the next year compared to the current price of 3.36.


Analysts
Analysts43.33
Price Target6.12 (82.14%)
EPS Next Y36.03%
Revenue Next YearN/A

GLTO Ownership

Ownership
Inst Owners14.52%
Ins Owners3.69%
Short Float %2.15%
Short Ratio1.23